{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:22:41Z","timestamp":1790050961797,"version":"4.0.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872743"],"award-info":[{"award-number":["81872743"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009659","name":"Guangzhou Medical University","doi-asserted-by":"publisher","award":["G2016013"],"award-info":[{"award-number":["G2016013"]}],"id":[{"id":"10.13039\/100009659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["20210208045 0"],"award-info":[{"award-number":["20210208045 0"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.cbi.2022.110122","type":"journal-article","created":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T09:31:28Z","timestamp":1661074288000},"page":"110122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Chlorquinaldol inhibits the activation of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein 3 inflammasome and ameliorates imiquimod-induced psoriasis-like dermatitis in mice"],"prefix":"10.1016","volume":"365","author":[{"given":"Yanhong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuli","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitao","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuorong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6359-0197","authenticated-orcid":false,"given":"Ping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2022.110122_bib1","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cbi.2022.110122_bib2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"Boehncke","year":"2015","journal-title":"Psoriasis, The Lancet"},{"key":"10.1016\/j.cbi.2022.110122_bib3","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.clindermatol.2007.08.011","article-title":"The cytokine and chemokine network in psoriasis","volume":"25","author":"Nickoloff","year":"2007","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.cbi.2022.110122_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13555-015-0092-3","article-title":"A review of biologic therapies targeting IL-23 and IL-17 for use in moderate-to-severe plaque psoriasis","volume":"6","author":"Campa","year":"2016","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.cbi.2022.110122_bib5","first-page":"30","article-title":"The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities, F1000 Med","volume":"1","author":"Yost","year":"2009","journal-title":"For. Rep."},{"key":"10.1016\/j.cbi.2022.110122_bib6","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor Alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2022.110122_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13581","article-title":"Monocyte-derived inflammatory Langerhans cells and dermal dendritic cells mediate psoriasis-like inflammation","volume":"7","author":"Singh","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cbi.2022.110122_bib8","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/jid.2012.512","article-title":"IL-1R1 signaling facilitates munro's microabscess formation in psoriasiform imiquimod-induced skin inflammation","volume":"133","author":"Uribe-Herranz","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cbi.2022.110122_bib9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","article-title":"A critical role of the IL-1\u03b2\u2013IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis","volume":"139","author":"Cai","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cbi.2022.110122_bib10","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1038\/sj.jid.5700922","article-title":"The activity of caspase-1 is increased in lesional psoriatic epidermis","volume":"127","author":"Johansen","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cbi.2022.110122_bib11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/jid.2013.438","article-title":"IL-1\u03b2 drives inflammatory responses to propionibacterium acnes in vitro and in vivo","volume":"134","author":"Kistowska","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cbi.2022.110122_bib12","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/exd.12049","article-title":"Genetic support for the role of the NLRP3 inflammasome in psoriasis susceptibility","volume":"21","author":"Carlstrom","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.cbi.2022.110122_bib13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jid.2020.07.012","article-title":"Enhanced inflammasome activity in patients with psoriasis promotes systemic inflammation","volume":"141","author":"Verma","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cbi.2022.110122_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00403-013-1327-8","article-title":"Interleukin-1 family members are enhanced in psoriasis and suppressed by vitamin D and retinoic acid","volume":"305","author":"Balato","year":"2013","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.cbi.2022.110122_bib15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/sji.12117","article-title":"Association of disease severity with IL-1 levels in methotrexate-treated psoriasis patients","volume":"78","author":"Tamilselvi","year":"2013","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.cbi.2022.110122_bib16","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.cbi.2022.110122_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/imr.12286","article-title":"Initiation and perpetuation of NLRP3 inflammasome activation and assembly","volume":"265","author":"Elliott","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cbi.2022.110122_bib18","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.jid.2018.11.031","article-title":"Caspase 1\/11 deficiency or pharmacological inhibition mitigates psoriasis-like phenotype in mice","volume":"139","author":"Aira","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cbi.2022.110122_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41420-020-0245-8","article-title":"Metformin inhibits IL-1\u03b2 secretion via impairment of NLRP3 inflammasome in keratinocytes: implications for preventing the development of psoriasis","volume":"6","author":"Tsuji","year":"2020","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.cbi.2022.110122_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/jid.1956.19","article-title":"Topical use of Chlorquinaldol1","volume":"26","author":"Robinson","year":"1956","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cbi.2022.110122_bib21","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2147\/IDR.S211007","article-title":"Chlorquinaldol, a topical agent for skin and wound infections: anti-biofilm activity and biofilm-related antimicrobial cross-resistance","author":"Bidossi","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.cbi.2022.110122_bib22","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3389\/fmicb.2017.01039","article-title":"In vitro antimicrobial activity of chlorquinaldol against microorganisms responsible for skin and soft tissue infections: comparative evaluation with gentamicin and fusidic acid","author":"Bortolin","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cbi.2022.110122_bib23","first-page":"115","article-title":"Comparison of chlorquinaldol-promestriene vaginal tablets and opin suppositories effect on inflammatory factors and immune function in chronic HPV cervicitis","volume":"29","author":"Chen","year":"2019","journal-title":"J. College Phys. Surg. Pakistan : JCPSP"},{"key":"10.1016\/j.cbi.2022.110122_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104955","article-title":"Chlorquinaldol targets the \u03b2-catenin and T-cell factor 4 complex and exerts anti-colorectal cancer activity","volume":"159","author":"Wang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2022.110122_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.558629","article-title":"Serum metabolomic profiling reveals the amelioration effect of methotrexate on imiquimod-induced psoriasis in mouse","volume":"11","author":"Zong","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2022.110122_bib26","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/bph.15306","article-title":"DGT, a novel heterocyclic diterpenoid, effectively suppresses psoriasis via inhibition of STAT3 phosphorylation","volume":"178","author":"Bian","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2022.110122_bib27","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/s41467-020-16043-9","article-title":"N-GSDMD trafficking to neutrophil organelles facilitates IL-1\u03b2 release independently of plasma membrane pores and pyroptosis","volume":"11","author":"Karmakar","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cbi.2022.110122_bib28","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.cell.2014.02.008","article-title":"Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes","volume":"156","author":"Lu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2022.110122_bib29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/nature16959","article-title":"NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux","volume":"530","author":"He","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2022.110122_bib30","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41586-019-1295-z","article-title":"Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome","volume":"570","author":"Sharif","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2022.110122_bib31","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.cbi.2022.110122_bib32","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.cell.2015.12.057","article-title":"NF-\u03baB restricts inflammasome activation via elimination of damaged mitochondria","volume":"164","author":"Zhong","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2022.110122_bib33","doi-asserted-by":"crossref","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cbi.2022.110122_bib34","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ni.3333","article-title":"NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component","volume":"17","author":"Shi","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cbi.2022.110122_bib35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0190-9622(88)80237-8","article-title":"Methotrexate in psoriasis: revised guidelines","volume":"19","author":"Roenigk","year":"1988","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cbi.2022.110122_bib36","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41586-018-0316-7","article-title":"Histidine catabolism is a major determinant of methotrexate sensitivity","volume":"559","author":"Kanarek","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2022.110122_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14053","article-title":"Ginsenoside Rg1 ameliorates psoriasis-like skin lesions by suppressing proliferation and NLRP3 inflammasomes in keratinocytes","volume":"46","author":"Mao","year":"2022","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.cbi.2022.110122_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105682","article-title":"Inhibition of NLRP3 inflammasome-mediated pyroptosis in macrophage by cycloastragenol contributes to amelioration of imiquimod-induced psoriasis-like skin inflammation in mice","volume":"74","author":"Deng","year":"2019","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.cbi.2022.110122_bib39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","article-title":"The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.cbi.2022.110122_bib40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cyto.2013.07.022","article-title":"IL-17 family: cytokines, receptors and signaling","volume":"64","author":"Gu","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.cbi.2022.110122_bib41","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1080\/1744666X.2020.1679625","article-title":"Anti IL-17 in psoriasis","volume":"15","author":"Ly","year":"2019","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.cbi.2022.110122_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cei.13449","article-title":"IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa","volume":"201","author":"Fletcher","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cbi.2022.110122_bib43","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.immuni.2020.12.010","article-title":"The TGF-\u03b2 superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation","volume":"54","author":"Wu","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.cbi.2022.110122_bib44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jneuroim.2016.01.014","article-title":"Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice","volume":"292","author":"Sun","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cbi.2022.110122_bib45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.clindermatol.2011.08.022","article-title":"Abnormal epidermal barrier in the pathogenesis of psoriasis","volume":"30","author":"Wolf","year":"2012","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.cbi.2022.110122_bib46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-0625.2011.01412.x","article-title":"IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion","volume":"21","author":"Gutowska-Owsiak","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.cbi.2022.110122_bib47","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jaci.2019.10.036","article-title":"Activated NLR family pyrin domain containing 3 (NLRP3) inflammasome in keratinocytes promotes cutaneous T-cell response in patients with vitiligo","volume":"145","author":"Li","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cbi.2022.110122_bib48","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.3390\/ijms18122514","article-title":"Models in the research process of psoriasis","volume":"18","author":"Boche\u0144ska","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2022.110122_bib49","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jid.2016.10.024","article-title":"The snowballing literature on imiquimod-induced skin inflammation in mice: a critical appraisal","volume":"137","author":"Hawkes","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cbi.2022.110122_bib50","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/17460441.2018.1463214","article-title":"Murine models of psoriasis and their usefulness for drug discovery","volume":"13","author":"Chuang","year":"2018","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.cbi.2022.110122_bib51","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"Griffiths","year":"2021","journal-title":"Psoriasis, The Lancet"},{"key":"10.1016\/j.cbi.2022.110122_bib52","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 Axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.cbi.2022.110122_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106767","article-title":"Hispidulin alleviates imiquimod-induced psoriasis-like skin inflammation by inhibiting splenic Th1\/Th17 cell population and keratinocyte activation","volume":"87","author":"Kim","year":"2020","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.cbi.2022.110122_bib54","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1021\/acs.jmedchem.9b00518","article-title":"Structure-aided identification and optimization of tetrahydro-isoquinolines as novel PDE4 inhibitors leading to discovery of an effective antipsoriasis agent","volume":"62","author":"Zhang","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2022.110122_bib55","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.bbrc.2005.01.159","article-title":"8-Hydroxyquinoline inhibits iNOS expression and nitric oxide production by down-regulating LPS-induced activity of NF-\u03baB and C\/EBP\u03b2 in Raw 264.7 cells","volume":"329","author":"Kim","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2022.110122_bib56","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ni.1831","article-title":"Thioredoxin-interacting protein links oxidative stress to inflammasome activation","volume":"11","author":"Zhou","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cbi.2022.110122_bib57","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12974-017-0895-5","article-title":"Isoliquiritigenin alleviates early brain injury after experimental intracerebral hemorrhage via suppressing ROS- and\/or NF-\u03baB-mediated NLRP3 inflammasome activation by promoting Nrf2 antioxidant pathway","volume":"14","author":"Zeng","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cbi.2022.110122_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113417","article-title":"Discovery of chalcone analogues as novel NLRP3 inflammasome inhibitors with potent anti-inflammation activities","volume":"219","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2022.110122_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107819","article-title":"Tanshinones inhibit NLRP3 inflammasome activation by alleviating mitochondrial damage to protect against septic and gouty inflammation","volume":"97","author":"Yue","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.cbi.2022.110122_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.496","article-title":"Screening-based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming","volume":"11","author":"Cui","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.cbi.2022.110122_bib61","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.3390\/ijms19123917","article-title":"Antioxidant properties and the formation of iron coordination complexes of 8-hydroxyquinoline","volume":"19","author":"Chobot","year":"2018","journal-title":"Int. J. Mol. Sci."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722003271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722003271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:24:44Z","timestamp":1777389884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279722003271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":61,"alternative-id":["S0009279722003271"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110122","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chlorquinaldol inhibits the activation of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein 3 inflammasome and ameliorates imiquimod-induced psoriasis-like dermatitis in mice","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110122"}}